1
Hubben, G.A.A., Bos, J.M., Glynn, D.M., van der Ende, A., van Alphen, L., Postma, M.J.
Veröffentlicht in: Hubben , G A A , Bos , J M , Glynn , D M , van der Ende , A , van Alphen , L & Postma , M J 2007 , ' Enhanced decision support for policy makers using a web interface to health-economic models - Illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands ' , Vaccine , vol. 25 , no. 18 , pp. 3669-3678 . https://doi.org/10.1016/j.vaccine.2007.01.088;
2007
Veröffentlicht in: Hubben , G A A , Bos , J M , Glynn , D M , van der Ende , A , van Alphen , L & Postma , M J 2007 , ' Enhanced decision support for policy makers using a web interface to health-economic models - Illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands ' , Vaccine , vol. 25 , no. 18 , pp. 3669-3678 . https://doi.org/10.1016/j.vaccine.2007.01.088;
2007
2
Rozenbaum, Mark H., van Hoek, Albert Jan, Hak, Eelko, Postma, Maarten J.
Veröffentlicht in: Rozenbaum , M H , van Hoek , A J , Hak , E & Postma , M J 2010 , ' Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar (R)) ' , Vaccine , vol. 28 , no. 12 , pp. 2367-2369 . https://doi.org/10.1016/j.vaccine.2010.01.005;
2010
Veröffentlicht in: Rozenbaum , M H , van Hoek , A J , Hak , E & Postma , M J 2010 , ' Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar (R)) ' , Vaccine , vol. 28 , no. 12 , pp. 2367-2369 . https://doi.org/10.1016/j.vaccine.2010.01.005;
2010
3
Wagenvoort, Gertjan H. J., Knol, Mirjam J., de Melker, Hester E., Vlaminckx, Bart J., van der Ende, Arie, Rozenbaum, Mark H., Sanders, Elisabeth A. M.
Veröffentlicht in: Wagenvoort , G H J , Knol , M J , de Melker , H E , Vlaminckx , B J , van der Ende , A , Rozenbaum , M H & Sanders , E A M 2016 , ' Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands ' , Vaccine , vol. 34 , no. 3 , pp. 334-340 . https://doi.org/10.1016/j.vaccine.2015.11.048;
2016
Veröffentlicht in: Wagenvoort , G H J , Knol , M J , de Melker , H E , Vlaminckx , B J , van der Ende , A , Rozenbaum , M H & Sanders , E A M 2016 , ' Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands ' , Vaccine , vol. 34 , no. 3 , pp. 334-340 . https://doi.org/10.1016/j.vaccine.2015.11.048;
2016